On Invalid Date, Zoetis (NYSE: ZTS) reported Q3 2022 earnings per share (EPS) of $1.13, up 2.59% year over year. Total Zoetis earnings for the quarter were $529.00 million. In the same quarter last year, Zoetis's earnings per share (EPS) was $1.16.
As of Q1 2023, Zoetis's earnings has grown 5.28% year over year. This is 1.14 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 4.14%. Zoetis's earnings in the past year totalled $2.07 billion.
On Invalid Date, Zoetis (NYSE: ZTS) reported Q3 2022 revenue of $2.00 billion up 0.6% year over year. In the same quarter last year, Zoetis's revenue was $1.99 billion.
What was ZTS's revenue growth in the past year?
As of Q1 2023, Zoetis's revenue has grown 5.13% year over year. This is 223.62 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 228.76%. Zoetis's revenue in the past year totalled $8.01 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.